CD19/CD22 bispecific chimeric antigen receptor‑NK‑92 cells are developed and evaluated
Hyori Kim(Asan Medical Center), Kyung‐Nam Koh(Ulsan College)
Cited by 14
Related Papers
Antibody-mediated blockade for galectin-3 binding protein in tumor secretome abrogates PDAC metastasis
|Proceedings of the National Academy of Sciences|2022|23